Helms, S. et al. 2021. Tocilizumab-Induced Limbic Encephalitis: Another Adverse Effect of Disrupted IL-6 Signalling?. Archives of Clinical and Medical Case Reports. 5, 5 (Oct. 2021), 704–709.